NSE - Delayed Quote INR

Hikal Limited (HIKAL.NS)

404.60
+1.95
+(0.48%)
At close: 3:30:02 PM GMT+5:30
Loading Chart for HIKAL.NS
  • Previous Close 402.65
  • Open 402.55
  • Bid --
  • Ask --
  • Day's Range 399.80 - 412.25
  • 52 Week Range 267.25 - 464.75
  • Volume 250,242
  • Avg. Volume 406,279
  • Market Cap (intraday) 49.888B
  • Beta (5Y Monthly) 0.66
  • PE Ratio (TTM) 54.90
  • EPS (TTM) 7.37
  • Earnings Date Jul 30, 2025 - Aug 4, 2025
  • Forward Dividend & Yield 1.20 (0.30%)
  • Ex-Dividend Date Feb 7, 2025
  • 1y Target Est 540.00

Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal health, biotech, crop protection, and specialty chemicals companies in India, the United States, Canada, Europe, South East Asia, and internationally. It operates through two segments, Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredients (APIs). Its Crop Protection segment manufactures pesticides and herbicides, which include diuron tech, temephos tech, thiacloprid tech, clothianidin tech, dichloroaniline, N-bromosuccinimide, prothioconazole technical, trifloxystrobin technical, and BIT. The company also collaborates with other companies; and offers solutions in contract research, custom synthesis, and custom manufacturing of intermediates and active ingredients. In addition, it offers human health products, such as anti-convulsant, anti-emetic, anti-histaminic, anti-depressant, anti-psychotic, anti-lipemic, hemorheologic, anti-diabetic, anti-thrombotic, anti-hypertensive, anti-inflammation, and analgesic; animal health products, such as anti-tick, anti-parasitic, analgesic, anabolic steroids, female sex hormone, and NSAID; and specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. The company also exports its products. The company was formerly known as Hikal Chemical Industries Ltd. and changed its name to Hikal Limited in April 2000. Hikal Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.

www.hikal.com

--

Full Time Employees

March 31

Fiscal Year Ends

Recent News: HIKAL.NS

View More

Performance Overview: HIKAL.NS

Trailing total returns as of 5/21/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

HIKAL.NS
3.77%
S&P BSE SENSEX (^BSESN)
4.42%

1-Year Return

HIKAL.NS
38.35%
S&P BSE SENSEX (^BSESN)
10.34%

3-Year Return

HIKAL.NS
6.99%
S&P BSE SENSEX (^BSESN)
50.20%

5-Year Return

HIKAL.NS
248.35%
S&P BSE SENSEX (^BSESN)
163.79%

Compare To: HIKAL.NS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: HIKAL.NS

View More

Valuation Measures

Annual
As of 5/20/2025
  • Market Cap

    49.62B

  • Enterprise Value

    56.43B

  • Trailing P/E

    54.71

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.69

  • Price/Book (mrq)

    3.93

  • Enterprise Value/Revenue

    3.06

  • Enterprise Value/EBITDA

    16.93

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.88%

  • Return on Assets (ttm)

    4.96%

  • Return on Equity (ttm)

    7.41%

  • Revenue (ttm)

    18.6B

  • Net Income Avi to Common (ttm)

    908M

  • Diluted EPS (ttm)

    7.37

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    180M

  • Total Debt/Equity (mrq)

    60.58%

  • Levered Free Cash Flow (ttm)

    808.52M

Research Analysis: HIKAL.NS

View More

Company Insights: HIKAL.NS

Research Reports: HIKAL.NS

View More

People Also Watch